endocrine metabolism diseases
Conditions
Interventions
Experimental group:Polyethylene glycol loxenatide injection
Sponsors
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients who have been diagnosed with schizophrenia, depression, mania and other mental illnesses; 2. The current condition is relatively stable and has the ability to independently complete the questionnaire; 3. No gender limit; 4. Willing to sign the informed consent to participate in this research.
Exclusion criteria
Exclusion criteria: 1. Pregnant; 2. Acute disease, infection or trauma, etc., those whose physical condition does not allow.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| uric acid;creatinine;urea;alanine aminotransferase;aspartate aminotransferase;total cholesterol;triglycerides;high density lipoprotein;low-density lipoprotein;total protein;albumin;total bilirubin;direct bilirubin;triiodothyronine;thyroxine;free triiodothyronine;free thyroxine;thyrotropin;anti-thyroglobulin antibody;anti-thyroid peroxidase antibody;follicle stimulating hormone;luteinizing hormone;testosterone;estradiol;25-hydroxyvitamin D;insulin;alpha-fetoprotein;carcinoembryonic antigen;glucose;glycated hemoglobin;blood routine examination;urine routine examination;glucagon;total type I collagen N-terminal extension peptides;osteocalcin N-terminal middle molecular fragment;ß-collagen degradation products; | — |
Countries
China
Contacts
Public ContactLu Yingli
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed